Testimonials

Find out what companies around the world are saying about working with us.
Client location
Client location with testimonial
Algorithme Pharma is an important partner in our development efforts and we recommend them for any ligand-binding requirements. Bryan Tayefeh | Assistant Director Alliance Management Ionis Pharmaceuticals, Inc. Read full testimonial
We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants. Hélène Dulude, B.Pharm., Ph.D. Director, Clinical Development Locemia Solutions ULC Read full testimonial
...the communication between our teams was optimal, from the first protocol draft to the delivery of final report. Maxime Ranger President and CEO gIcare pharma inc Read full testimonial
It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions. Marie-Francoise TEMAM Associate Director, Clinical Operations Idenix, a wholly-owned subsidiary of Merck & Company Read full testimonial

I am writing to recommend the services of Algorithme Pharma, with whom Ionis Pharmaceuticals, Inc., (formely known as Isis Pharmaceuticals) have partnered to conduct ultrafiltration protein binding, multiplexing through an innovative platform, and quantitative Hybridization ELISA assays for concentration determination. Several matrices in various species were assayed, including Plasma, Brain, Spinal Cord, Liver, Kidney and Ocular tissues.

Throughout the entirety of the programs, Algorithme Pharma has distinguished itself by:

  • Their expertise in effectively and efficiently transferring and validating method assays
  • Their flexibility and versatility in managing internal resources to accommodate change, and ensure timelines are met
  • Their use of quality systems, providing reliable and concrete results
  • Their proactive and transparent communication to ensure that we remained well informed of study developments and analysis progress

Algorithme Pharma is an important partner in our development efforts and we recommend them for any ligand-binding requirements.

Sincerely,

Bryan Tayefeh | Assistant Director
Alliance Management
Ionis Pharmaceuticals